Wellington Management Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,085,392
Closed -$9.45M 1988
2025
Q1
$9.45M Buy
2,085,392
+126,264
+6% +$668K ﹤0.01% 1214
2024
Q4
$13.9M Buy
1,959,128
+98,447
+5% +$784K ﹤0.01% 1098
2024
Q3
$15.1M Sell
1,860,681
-25,177
-1% -$182K ﹤0.01% 1048
2024
Q2
$12.1M Sell
1,885,858
-740,477
-28% -$4.75M ﹤0.01% 1113
2024
Q1
$19.8M Sell
2,626,335
-513,947
-16% -$4.69M ﹤0.01% 948
2023
Q4
$29.1M Buy
3,140,282
+139,682
+5% +$1.14M 0.01% 857
2023
Q3
$30.4M Sell
3,000,600
-810
-0% -$9.67K 0.01% 842
2023
Q2
$37.5M Buy
3,001,410
+162,941
+6% +$1.94M 0.01% 782
2023
Q1
$33.1M Buy
2,838,469
+1,470,287
+107% +$18.7M 0.01% 804
2022
Q4
$14.5M Sell
1,368,182
-1,145,179
-46% -$11.1M ﹤0.01% 988
2022
Q3
$24.4M Sell
2,513,361
-191,185
-7% -$2.53M 0.01% 856
2022
Q2
$39.2M Sell
2,704,546
-964,485
-26% -$16.4M 0.01% 742
2022
Q1
$95.9M Buy
3,669,031
+55,026
+2% +$1.56M 0.02% 590
2021
Q4
$143M Buy
3,614,005
+736,229
+26% +$33.6M 0.02% 536
2021
Q3
$144M Buy
2,877,776
+276,695
+11% +$15.1M 0.02% 519
2021
Q2
$144M Sell
2,601,081
-209,847
-7% -$11.2M 0.02% 532
2021
Q1
$131M Sell
2,810,928
-37,669
-1% -$1.82M 0.02% 525
2020
Q4
$124M Buy
2,848,597
+151,772
+6% +$5.6M 0.02% 533
2020
Q3
$98.7M Buy
2,696,825
+833,534
+45% +$28.3M 0.02% 520
2020
Q2
$54.4M Buy
1,863,291
+1,520,307
+443% +$42M 0.01% 682
2020
Q1
$8.97M Buy
342,984
+330,784
+2,711% +$10.1M ﹤0.01% 1061
2019
Q4
$423K Sell
12,200
-75,470
-86% -$2.5M ﹤0.01% 1883
2019
Q3
$2.77M Buy
+87,670
New +$3.45M ﹤0.01% 1499

Other funds holding HCAT

Wellington Management Group's HCAT Position: Q2 2025 in Review

Wellington Management Group sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 2,085,392 shares — an estimated $9.45M sold.

Wellington Management Group first reported a position in HCAT in Q3 2019 and held it in 23 quarters. The position peaked at $144M in Q2 2021. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Wellington Management Group reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 2,085,392 Health Catalyst shares in Q2 2025, an estimated $9.45M.
  • Wellington Management Group first reported a position in Health Catalyst in Q3 2019 and held it in 23 quarters.
  • Wellington Management Group's Health Catalyst position peaked at $144M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.